BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24631426)

  • 1. Rasch analysis for assessing unidimensionality and identifying measurement biases of malignancy scores in oncology. The example of the Weiss histopathological system for the diagnosis of adrenocortical cancer.
    Coste J; Tissier F; Pouchot J; Ecosse E; Rouquette A; Bertagna X; Libé R; Viallon V
    Cancer Epidemiol; 2014 Apr; 38(2):200-8. PubMed ID: 24631426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critique of Rasch analysis using the Dyspnoea-12 as an illustrative example.
    Yorke J; Horton M; Jones PW
    J Adv Nurs; 2012 Jan; 68(1):191-8. PubMed ID: 21658094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining the conceptual basis for rehabilitation outcome measurement: personal care and instrumental activities domain.
    Coster WJ; Haley SM; Andres PL; Ludlow LH; Bond TL; Ni PS
    Med Care; 2004 Jan; 42(1 Suppl):I62-72. PubMed ID: 14707756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity outcome measurement for postacute care.
    Haley SM; Coster WJ; Andres PL; Ludlow LH; Ni P; Bond TL; Sinclair SJ; Jette AM
    Med Care; 2004 Jan; 42(1 Suppl):I49-61. PubMed ID: 14707755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the measurement of health-related quality of life in adolescent with idiopathic scoliosis: the SRS-7, a Rasch-developed short form of the SRS-22 questionnaire.
    Caronni A; Zaina F; Negrini S
    Res Dev Disabil; 2014 Apr; 35(4):784-99. PubMed ID: 24521663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring disability in Medicare home care patients: application of Rasch modeling to the outcome and assessment information set.
    Fortinsky RH; Garcia RI; Joseph Sheehan T; Madigan EA; Tullai-McGuinness S
    Med Care; 2003 May; 41(5):601-15. PubMed ID: 12719685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis.
    Lamoureux EL; Pallant JF; Pesudovs K; Hassell JB; Keeffe JE
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing alternative Rasch-based methods vs raw scores in measuring change in health.
    Norquist JM; Fitzpatrick R; Dawson J; Jenkinson C
    Med Care; 2004 Jan; 42(1 Suppl):I25-36. PubMed ID: 14707753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why measurement matters for measuring patient vision outcomes.
    Mallinson T
    Optom Vis Sci; 2007 Aug; 84(8):675-82. PubMed ID: 17700332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.
    Mondal SK; Dasgupta S; Jain P; Mandal PK; Sinha SK
    J Cancer Res Ther; 2013; 9(3):436-41. PubMed ID: 24125979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rasch analysis of the Fatigue Severity Scale in multiple sclerosis.
    Mills R; Young C; Nicholas R; Pallant J; Tennant A
    Mult Scler; 2009 Jan; 15(1):81-7. PubMed ID: 18755824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.
    de Reyniès A; Assié G; Rickman DS; Tissier F; Groussin L; René-Corail F; Dousset B; Bertagna X; Clauser E; Bertherat J
    J Clin Oncol; 2009 Mar; 27(7):1108-15. PubMed ID: 19139432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Edinburgh Post Natal Depression Scale using Rasch analysis.
    Pallant JF; Miller RL; Tennant A
    BMC Psychiatry; 2006 Jun; 6():28. PubMed ID: 16768803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Weiss system: a still in-use diagnostic tool for the assessment of adrenocortical malignancy].
    Aubert S; Buob D; Leroy X; Devos P; Carnaille B; Do Cao C; Wemeau JL; Leteurtre E
    Ann Pathol; 2005 Dec; 25(6):545-54. PubMed ID: 16735978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Item banking: a generational change in patient-reported outcome measurement.
    Pesudovs K
    Optom Vis Sci; 2010 Apr; 87(4):285-93. PubMed ID: 20142792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale.
    van Nes SI; Vanhoutte EK; Faber CG; Garssen M; van Doorn PA; Merkies IS;
    J Peripher Nerv Syst; 2009 Dec; 14(4):268-78. PubMed ID: 20021568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal construct validity of the Oxford Knee Scale: evidence from Rasch measurement.
    Conaghan PG; Emerton M; Tennant A
    Arthritis Rheum; 2007 Dec; 57(8):1363-7. PubMed ID: 18050174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis.
    Nijsten T; Unaeze J; Stern RS
    Br J Dermatol; 2006 Apr; 154(4):692-700. PubMed ID: 16536813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the Individual Work Performance Questionnaire using Rasch analysis.
    Koopmans L; Bernaards CM; Hildebrandt VH; van Buuren S; van der Beek AJ; de Vet HC
    J Appl Meas; 2014; 15(2):160-75. PubMed ID: 24950534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological studies of orofacial aesthetics, orofacial function and oral health-related quality of life.
    Larsson P
    Swed Dent J Suppl; 2010; (204):11-98. PubMed ID: 20623943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.